These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 28592737)
1. [Octreotide LAR was useful for avoiding hypoglycemia in an elderly patient with insulinoma]. Kanno A; Ide K; Kurita K; Terano T; Yamamoto K Nihon Ronen Igakkai Zasshi; 2017; 54(2):172-178. PubMed ID: 28592737 [TBL] [Abstract][Full Text] [Related]
2. Medical treatment of benign insulinoma using octreotide LAR: a case report. Usukura M; Yoneda T; Oda N; Yamamoto Y; Takata H; Hasatani K; Takeda Y Endocr J; 2007 Feb; 54(1):95-101. PubMed ID: 17124362 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients. Kishikawa H; Okada Y; Hirose A; Tanikawa T; Kanda K; Tanaka Y Endocr J; 2006 Feb; 53(1):79-85. PubMed ID: 16543676 [TBL] [Abstract][Full Text] [Related]
4. Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma. Katabami T; Kato H; Shirai N; Naito S; Saito N Endocr J; 2005 Oct; 52(5):629-34. PubMed ID: 16284444 [TBL] [Abstract][Full Text] [Related]
5. Glucose-responsive and octreotide-sensitive insulinoma. Izumiyama H; Gotyo N; Fukai N; Ozawa N; Doi M; Yoshimoto T; Arii S; Hirata Y Intern Med; 2006; 45(8):519-24. PubMed ID: 16702744 [TBL] [Abstract][Full Text] [Related]
6. A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections. Okamoto M; Kishimoto M; Takahashi Y; Osame K; Noto H; Yamamoto-Honda R; Kajio H; Tokuhara M; Edamoto Y; Endo H; Igari T; Kubota K; Noda M Endocr J; 2013; 60(8):951-7. PubMed ID: 23665775 [TBL] [Abstract][Full Text] [Related]
7. Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report. Skajaa GO; Mathiesen ER; Iyore E; Beck-Nielsen H; Jimenez-Solem E; Damm P BMC Res Notes; 2014 Nov; 7():804. PubMed ID: 25404386 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic usefulness of radiolabeled pentetreotide scintigraphy and therapeutic efficiency of octreotide in a case of insulinoma. Cuvelier C; Pochet JM; Col V; Jonard P; Pauwels S; Cuvelier A Acta Clin Belg; 1994; 49(6):296-301. PubMed ID: 7871936 [TBL] [Abstract][Full Text] [Related]
9. Effects of octreotide on circulating islet B cell products in endogenous hyperinsulinism. Krentz AJ; Pace J; Somerville W; Clark PM; Nattrass M Postgrad Med J; 1993 Sep; 69(815):735-8. PubMed ID: 8255845 [TBL] [Abstract][Full Text] [Related]
10. Possible functional regression of insulinoma with prolonged octreotide. Craig CE; Gallen IW Postgrad Med J; 2002 Oct; 78(924):623-4. PubMed ID: 12415090 [TBL] [Abstract][Full Text] [Related]
11. The effectiveness of administering a minimal dose of octreotide long-term prior to surgery for insulinoma: report of a case. Tanaka Y; Funahashi H; Imai T; Naruse T; Suzumura K; Oda Y Surg Today; 2000; 30(6):541-3. PubMed ID: 10883468 [TBL] [Abstract][Full Text] [Related]
12. A rare case of insulinoma presenting with postprandial hypoglycemia. Shreenivas AV; Leung V Am J Case Rep; 2014 Nov; 15():488-91. PubMed ID: 25381469 [TBL] [Abstract][Full Text] [Related]
13. Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy. van Schaik E; van Vliet EI; Feelders RA; Krenning EP; Khan S; Kamp K; Valkema R; van Nederveen FH; Teunissen JJ; Kwekkeboom DJ; de Herder WW J Clin Endocrinol Metab; 2011 Nov; 96(11):3381-9. PubMed ID: 21917872 [TBL] [Abstract][Full Text] [Related]
14. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report. Alberts AS; Falkson G S Afr Med J; 1988 Jul; 74(2):75-6. PubMed ID: 2899913 [TBL] [Abstract][Full Text] [Related]
15. Treatment with somatostatin analogs and chemoembolization of liver metastases for severe hypoglycemia in malignant insulinomas. Maiza JC; Vezzosi D; Grunenwald S; Otal P; Guimbaud R; Bennet A; Caron P J Endocrinol Invest; 2011 Oct; 34(9):e253-8. PubMed ID: 21623151 [TBL] [Abstract][Full Text] [Related]
16. [Preoperative treatment of hypoglycemia caused by an insulinoma with the somatostatin analog SMS 201-995]. Sánchez García Cervigón P; Fernández Navarro JI; Salmerón de Diego J; Caballero Asensi A; Cornelio Hernández F; Jara Albarrán A Med Clin (Barc); 1987 Oct; 89(12):511-3. PubMed ID: 2890800 [No Abstract] [Full Text] [Related]
17. Evaluation of the long-acting somatostatin analogue octreotide in the management of insulinoma in three dogs. Simpson KW; Stepien RL; Elwood CM; Boswood A; Vaillant CR J Small Anim Pract; 1995 Apr; 36(4):161-5. PubMed ID: 7603057 [TBL] [Abstract][Full Text] [Related]
18. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362 [TBL] [Abstract][Full Text] [Related]